Meningococcal Vaccines Market Report

Global and Europe Meningococcal Vaccines Market Professional Survey Report 2019

  • POSTDATE：Jun 22, 2020
  • PAGES：207
  • REPORT CODE：GMM580457
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Meningococcal Vaccines market was valued at XX.0 million US$ in 2018, with the CAGR of 8.4%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Meningococcal Vaccines market. Describe product range of Meningococcal Vaccines, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Meningococcal Vaccines market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Meningococcal Vaccines market.

     

    By Player

    • GlaxoSmithKline

    • Sanofi

    • JN-International Medical

    • Novartis International

    • Pfizer

    • Baxter International

    By Type

    • Menactra

    • Menomune

    By End-User

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

      • 1.3.2 Global Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Meningococcal Vaccines Market Size and Growth Rate of Pneumonia from 2014 to 2026

      • 1.4.2 Global Meningococcal Vaccines Market Size and Growth Rate of Meningitis from 2014 to 2026

      • 1.4.3 Global Meningococcal Vaccines Market Size and Growth Rate of Bacteremia from 2014 to 2026

      • 1.4.4 Global Meningococcal Vaccines Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Meningococcal Vaccines Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Meningococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Meningococcal Vaccines by Major Types

      • 3.4.1 Meningococcal Vaccines Market Size and Growth Rate of Menactra

      • 3.4.2 Meningococcal Vaccines Market Size and Growth Rate of Menomune

    4 Segmentation of Meningococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Meningococcal Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Meningococcal Vaccines for Pneumonia

      • 4.4.2 Market Size and Growth Rate of Meningococcal Vaccines for Meningitis

      • 4.4.3 Market Size and Growth Rate of Meningococcal Vaccines for Bacteremia

      • 4.4.4 Market Size and Growth Rate of Meningococcal Vaccines for Others (Arthritis, Conjunctivitis, Urethritis)

    5 Market Analysis by Major Regions

    • 5.1 Global Meningococcal Vaccines Production Analysis by Top Regions

    • 5.2 Global Meningococcal Vaccines Consumption Analysis by Top Regions

    • 5.3 Global Meningococcal Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Meningococcal Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Meningococcal Vaccines Landscape Analysis

    • 7.1 North America Meningococcal Vaccines Landscape Analysis by Top Countries

      • 7.1.1 United States Meningococcal Vaccines Market Volume and Growth Rate

      • 7.1.2 Canada Meningococcal Vaccines Market Volume and Growth Rate

      • 7.1.3 Mexico Meningococcal Vaccines Market Volume and Growth Rate

    8. Europe Meningococcal Vaccines Landscape Analysis

    • 8.1 Europe Meningococcal Vaccines Landscape Analysis by Major Types

    • 8.2 Europe Meningococcal Vaccines Landscape Analysis by Major End-Users

    • 8.3 Europe Meningococcal Vaccines Landscape Analysis by Top Countries

      • 8.3.1 Germany Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.2 UK Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.3 France Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.4 Italy Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.5 Spain Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.6 Belgium Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.7 Poland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.8 Russia Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.9 Turkey Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.10 Netherlands Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.11 Portugal Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.12 Denmark Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.13 Finland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.14 Iceland Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.15 Norway Meningococcal Vaccines Market Volume and Growth Rate

      • 8.3.16 Sweden Meningococcal Vaccines Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Meningococcal Vaccines Landscape Analysis

    • 9.1 Asia Pacific Meningococcal Vaccines Landscape Analysis by Top Countries

      • 9.1.1 China Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.2 Japan Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.4 India Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.5 ASEAN Meningococcal Vaccines Market Volume and Growth Rate

      • 9.1.6 South Korea Meningococcal Vaccines Market Volume and Growth Rate

    10 LAMEA Meningococcal Vaccines Landscape Analysis

    • 10.1 LAMEA Meningococcal Vaccines Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.2 Brazil Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.3 North Africa Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.4 South Africa Meningococcal Vaccines Market Volume and Growth Rate

      • 10.1.5 Argentina Meningococcal Vaccines Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 JN-International Medical

      • 11.3.1 JN-International Medical Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Novartis International

      • 11.4.1 Novartis International Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Pfizer

      • 11.5.1 Pfizer Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Baxter International

      • 11.6.1 Baxter International Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 76 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • Figure Global Meningococcal Vaccines Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • Figure Global Meningococcal Vaccines Market Size and Growth Rate of Meningitis from 2014 to 2026

    • Figure Global Meningococcal Vaccines Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • Figure Global Meningococcal Vaccines Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • Figure North America Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure United States Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure China Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure India Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Meningococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Meningococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Menactra

    • Figure Market Size and Growth Rate of Menomune

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pneumonia

    • Figure Market Size and Growth Rate of Meningitis

    • Figure Market Size and Growth Rate of Bacteremia

    • Figure Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis)

    • Table Global Meningococcal Vaccines Production by Major Regions

    • Table Global Meningococcal Vaccines Production Share by Major Regions

    • Table Global Meningococcal Vaccines Consumption by Major Regions

    • Table Global Meningococcal Vaccines Consumption Share by Major Regions

    • Table North America Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Europe Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table LAMEA Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table North America Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2014

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2018

    • Figure North America Meningococcal Vaccines Consumption Share by Major Countries in 2026

    • Figure United States Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Europe Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure China Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure India Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of JN-International Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JN-International Medical

    • Figure Sales and Growth Rate Analysis of JN-International Medical

    • Figure Revenue and Market Share Analysis of JN-International Medical

    • Table Product and Service Introduction of JN-International Medical

    • Table Company Profile and Development Status of Novartis International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International

    • Figure Sales and Growth Rate Analysis of Novartis International

    • Figure Revenue and Market Share Analysis of Novartis International

    • Table Product and Service Introduction of Novartis International

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Baxter International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International

    • Figure Sales and Growth Rate Analysis of Baxter International

    • Figure Revenue and Market Share Analysis of Baxter International

    • Table Product and Service Introduction of Baxter International

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US